415 is a San Francisco based venture capital firm founded in 2013 by Owen Van Natta and Grace Stanat. They provide seed stage funding and advice in the areas of strategy, funding, deals and partnerships, social, e- and m-commerce, operations, acquisition and engagement, culture and growth.
415's investments include Holloway, Qulab, Smarter Sorting, Vidrovr, Prellis Biologics, CATALOG, MetaBrite, Lemonaid Health, SwiftComply and Tractable.
Their exits include talech, Vessel and Spiral Genetics.
Timeline
Funded Companies
Prellis Biologics is developing technology to build transplantable human organs and tissues.
A provider of an online telemedicine service in California and focuses on creating a revolutionized patient experience and improving and optimizing clinical care through the advancements in machine learning and AI.
People
Further reading
Documentaries, videos and podcasts
Companies
References
Company attributes
Categories
Related Topics
Contributors
- 1
Aleksander Holm
Interested in understanding the world we live in. - 2
Edita Rexha
Economist - 3
Reys Phillips
A graduate of Cleveland State University with a Bachelor of Science in Education. My main hobbies include story writing and reading. - 4
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 5
Rachel Phythian
Advisor / Investor